Similar articles

• Dose response and frequency of administration of atenolol in essential hypertension--once daily treatment with beta-blockade.

  Marshall AJ, Barritt DW, Harry JD. Marshall AJ, et al. Postgrad Med J. 1977;53 Suppl 3:168-72. Postgrad Med J. 1977. PMID: 337271 Clinical Trial. No abstract available.
• [Spironolactone-thiazides-reserpine. Antihypertensive effect in essential arterial hypertension].

  de los Rios JC, Ortíz Feijoo J, Otero Cagide F. de los Rios JC, et al. Prensa Med Mex. 1976 Jul-Aug;41(7-8):210-4. Prensa Med Mex. 1976. PMID: 796845 Clinical Trial. Spanish. No abstract available.
• [Efficacy and tolerability of a cardioselective beta-blocking drug (atenolol) in the treatment of essential hypertension. A double blind study (author's transl)].

  Rengo F, Trimarco B, Petretta M, Ferrara N, Bonaduce D, Chiariello M, Condorelli M. Rengo F, et al. G Ital Cardiol. 1978;8(8):861-7. G Ital Cardiol. 1978. PMID: 359398 Clinical Trial. Italian.
• Hypertension in the elderly: treatment.

  Schulman SP, Gerstenblith G. Schulman SP, et al. Cardiol Clin. 1986 May;4(2):245-52. Cardiol Clin. 1986. PMID: 2871936 Review.
• Perindopril.

  O'Loughlin DC, Chu VL, Singh D. O'Loughlin DC, et al. Heart Dis. 2000 Nov-Dec;2(6):446-55. Heart Dis. 2000. PMID: 11728296 Review.